Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression

Virology

Volumn 214, Issue 2, 1995, Pages 512-521

  Mitra, Debashis ^a   Sikder, Santosh K ^a,b   Laurence, Jeffrey ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0029563570     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1995.0062     Document Type: Article

References (41)

1. Akerblom, I. E., Slater, E. P., Beato, M., Baxter, J. D., and Mellon, P. L. (1988). Negative regulation by glucocorticoids through Interference with a cAMP responsive enhancer. Science 241, 350.
2. Andrieu, J. M., Lu, W., and Levy, R. (1995). Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type-1 seropositive patients treated with prednisolone for 1 year. J. Infect. Dis. 171, 523.
3. Arya, S. K., Guo, C., Josephs, S. F., and Wong-Staal, F. (1985). Transactivator gene of human T-lymphotrophic virus type III (HTLV-III). Science 229, 69.
4. Beato, M. (1991). Transcriptional control by nuclear receptors. FASEB J. 5, 2044.
5. Cato, A. C. B., Skroch, P., Weinman, J., Butkeraitis, P., and Ponta, H. (1988). DNA sequences outside the receptor-binding sites differentially modulate the responsiveness of the mouse mammary tumor virus promoter to various steroid hormones, EMBO J. 7, 1403.
6. Chan, W. K., Klock, G., and Bernard, H. V. (1989). Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J. Virol. 63, 3261.
7. Chatterjee, V. K. K., Madison, L. D., Mayo, S., and Jameson, J. L. (1991). Repression of the human glycoprotein hormone a-subunit gene by glucocorticoids: Evidence for receptor interactions with limiting transcriptional activators. Mol. Endocrinol. 5, 100.
8. Cordinely, M. G., Riegel, A. T., and Hager, G. L. (1987). Steroid-dependent interaction of transcription factors with the inducible promoter of mouse mammary tumor virus in vivo. Cell 48, 261.
9. Cullen, B. R. (1991). Regulation of gene expression in the human immunodeficiency virus type 1. Adv. Virus Res. 40, 1-17.
10. Denton, R. R., Eisen, L. F., Elasser, M. S., and Harmon, J. M. (1993). Differential autoregulation of glucocorticoid receptor expression in human T and B cell lines. Endocrinology 133, 248.
11. Desai-Yajnik, V., Hadzic, E., Modlinger, P., Malhotra, S., Gechlik, G., and Samuels, H. H. (1995). Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator. J. Virol. 69, 5103.
12. Drouin, J., Trifiro, M. A., Plante, R. K., Nemer, M., Eriksson, P., and Wrange, O. (1989). Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of proopiomelanocortin gene transcription. Mol. Cell. Biol. 9, 5305.
13. Garcia, J. A., Harrich, D., Soultankis, E., Wu, F., Mitsuyasu, R., and Gaynor, R. B. (1989). Human immunodeficiency virus type 1 LTRTATA and TAR region sequence required for transcriptional regulation. EMBO J. 8, 765.
14. Ghosh, D. (1992). Glucocorticoid receptor-binding site in the human immunodeficiency virus long terminal repeat. J. Virol. 66, 586.
15. Giguere, V., Hollenberg, S. M., Rosenfield, M. G., and Evans, R. M. (1986). Functional domains of the human glucocorticoid receptor. Cell 46, 645.
16. Grunstein, M., and Hogness, D. (1975). Colony hybridization: A method for isolation of cloned DNAs that contain a specific gene. Proc. Natl. Acad. Sci. USA 72, 3961.
17. Herrlich, P., and Ponta, H. (1994). Mutual cross-modulation of steroid/retinoic acid receptor and AP-1 transcription factor activities. Trends Endocrinol. Metab. 5, 341.
18. Hollan, T., and Yoshimura, F. K. (1989). Variation in enzymatic transient gene expression assays. Anal. Biochem. 182, 411.
19. Jones, K. A., Luciw, P. A., and Duchange, N. (1988). Structural arrangements of transcription control domains within the 5' untranslated regions of the HIV-1 and HIV-2 promoters. Genes & Dev. 2, 1101.
20. Knudsen, P. J., Dinarello, C. A., and Strom, T. B. (1982). Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J. Immunol. 139, 4129.
21. Kolesnitchenko, V., and Snart, R. S. (1992). Regulatory elements in the human immunodeficiency virus type 1 long terminal repeat LTR (HIV-1) responsive to steroid hormone stimulation. AIDS Res. Hum. Retroviruses 8, 1977.
22. Kupfer, S., and Summers, W. C. (1990). Identification of a glucocorticoid-responsive element in Epstein-Barr Virus. J. Virol. 64, 1984.
23. Laurence, J., Sellers, M. B., and Sikder, S. K. (1989). Effect of glucocorticoids on chronic human immunodeficiency virus (HIV) infection and HIV promoter-mediated transcription. Blood 74, 291.
24. Lu, W., Salerno-Goncalves, R., Yuan, J., Sylvie, D., Han, D.-S., and An-drieu, J.-M. (1995). Glucocorticoids rescue CD4+ T lymphocytes from activation-induced apoptosis triggered by HIV-1: implications for pathogenesis and therapy. AIDS 9, 35.
25. Martinez, E., and Wahli, W. (1991). Characterization of hormone response elements. In "Nuclear Hormone Receptors'' (M. G. Parker, Ed.), p. 125.
26. Mattern, C. F. T., Murray, K., Jensen, A., Farzadegan, H., Pang, J., and Modlin, J. F. (1992). Localization of human immunodeficiency virus core antigen in term human placentas. Pediatrics 89, 207.
27. Miksicek, R., Heber, A., Schmid, W., Danesch, U., Posseckert, G., Beato, M., and Schutz, G. (1986). Glucocorticoid responsiveness of the transcriptional enhancer of Moloney murine sarcoma virus. Cell 46, 283.
28. Mitra, D., Sikder, S., and Laurence, J. (1993). Inhibition of tat-activated, HIV-1 LTR-mediated gene expression by glucocorticoids. AIDS Res. Hum. Retroviruses 9, 1055.
29. Moses, A. V., Ibanez, C., Gaynor, R., Ghazal, P., and Nelson, J. A. (1994). Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages. J. Virol. 68, 298.
30. Myers, G., Korber, B., Berzofsky, J. A., Smith, R. F., and Pavlakis, G. N. Eds. (1991). ''Human Retroviruses and AIDS 1991.'' Theoretical Biology and Biophysics Group, Los Alamos, NM.
31. Nabel, G. J., and Baltimore, D. (1987). An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326, 711.
32. Osborne, L., Kunkel, S., and Nabel, G. J. (1989). Tumor necrosis factor alpha and interleukin I stimulate the HIV enhancer by activation of the nuclear factor kB. Proc. Natl. Acad. Sci. USA 86, 2336.
33. Refaeli, Y., Levy, D. N., and Weiner, D. B. (1995). The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. AIDS Res. Hum. Retroviruses 11, S90 [Abstract 104]
34. Scheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A., and Baldwin, A. S., Jr. (1995). Characterization of mechanisms involved in transrepression of NF-kB by activated glucocorticoid receptors. Mol. Cell. Biol. 15, 943.
35. Schule, R., Umesono, K., Mangelsdorf, D. J., Bolado, J., Pike, J. W., and Evans, R. M. (1990). Jun-fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 61, 497.
36. Sikder, S. K., Mitra, D., and Laurence, J. (1994). Identification of a novel cell-type and context specific enhancer within the negative regulatory element of the human immunodeficiency virus type 1 long terminal repeat. Arch. Virol. 137, 139.
37. Soudeyns, H., Schneider, W., Geleziunas, R., Shyamala, G. S., and Wainberg, M. A. (1989). Effect of hydrocortisone on the replication of HIV-1 in different cell types. Vth International AIDS Conference Montreal, June 4-9. [Abstract TCP 110]
38. Soudeyns, H., Geleziunas, R., Shyamala, G. S., Hiscott, J., and Wainberg, M. A. (1993). Identification of a novel glucocorticoid response element within the genome of the human immunodeficiency virus type 1. Virology 194, 758.
39. Tsai, Y. S., Duke, J. C., Weigel, N. L., Dahlman, K., Gustafsson, J. A., Tsai, M. J., and O'Malley, B. W. (1988). Molecular interactions of steroid hormone receptor with its enhancer element: Evidence for receptor dimer formation. Cell 55, 361.
40. Yoon, J. B., Li, G., and Roeder, R. G. (1994). Characterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vivo. Mol. Cell. Biol. 14, 1776.
41. Zeichner, S. L., Kim, J. Y. H., and Alwine, J. C. (1991). Linker-scanning mutational analysis of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 65, 2436.